Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03355534
Other study ID # XJH-A-2017-10-10
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 5, 2018
Est. completion date December 30, 2020

Study information

Verified date May 2022
Source Air Force Military Medical University, China
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Dexmedetomidine induces analgesic and sedative effects and is reported to decrease agitation during emergence after general anesthesia in various surgeries. For patients undergoing cranial aneurysm surgeries, a calm anesthesia and emergence is important. In this study, the investigatorstend to observe the effect of dexmedetomidine on maintenance and recovery of patients undergoing cranial aneurysm surgeries.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date December 30, 2020
Est. primary completion date December 30, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - patients undergoing cerebral aneurysm embolism under general anesthesia Exclusion Criteria: - patients with bradycardia or atrioventricular heart block - patients with ASA(American Society of Anesthesiologists) status over 3 - patients with body mass index(BMI)=30kg/m2 - patients with difficulty in communication - patients with ruptured aneurysm - patients suspected or proved to be pregnant

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Intravenous dexmedetomidine
drug is intravenously infused to patients
nasal dexmedetomidine
drug is nasally given to patients
intravenous saline
saline is given to patients intravenously
nasal saline
normal saline is given to patients nasally

Locations

Country Name City State
China Xijing Hospital Xi'an Shaanxi

Sponsors (1)

Lead Sponsor Collaborator
Zhihong LU

Country where clinical trial is conducted

China, 

References & Publications (5)

Elbakry AE, Ibrahim E. Propofol-dexmedetomidine versus propofol-remifentanil conscious sedation for awake craniotomy during epilepsy surgery. Minerva Anestesiol. 2017 Dec;83(12):1248-1254. doi: 10.23736/S0375-9393.17.11873-0. Epub 2017 Jun 14. — View Citation

Jun JH, Kim KN, Kim JY, Song SM. The effects of intranasal dexmedetomidine premedication in children: a systematic review and meta-analysis. Can J Anaesth. 2017 Sep;64(9):947-961. doi: 10.1007/s12630-017-0917-x. Epub 2017 Jun 21. Review. — View Citation

Peng K, Wu S, Liu H, Ji F. Dexmedetomidine as an anesthetic adjuvant for intracranial procedures: meta-analysis of randomized controlled trials. J Clin Neurosci. 2014 Nov;21(11):1951-8. doi: 10.1016/j.jocn.2014.02.023. Epub 2014 Jun 25. — View Citation

Soliman RN, Hassan AR, Rashwan AM, Omar AM. Prospective, randomized controlled study to assess the role of dexmedetomidine in patients with supratentorial tumors undergoing craniotomy under general anesthesia. Middle East J Anaesthesiol. 2011 Feb;21(1):23 — View Citation

Sun Y, Li Y, Sun Y, Wang X, Ye H, Yuan X. Dexmedetomidine Effect on Emergence Agitation and Delirium in Children Undergoing Laparoscopic Hernia Repair: a Preliminary Study. J Int Med Res. 2017 Jun;45(3):973-983. doi: 10.1177/0300060517699467. Epub 2017 Ma — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary incidence of coughing from end of infusing anesthetics to 2 minutes after extubation, averagely 30 minutes
Secondary Ricker's agitation-sedation score from end of infusing anesthetics to 2 minutes after extubation, averagely 30 minutes
Secondary score of coughing 0=no coughing;1=intermittent coughing;2=continuous coughing from end of infusing anesthetics to 2 minutes after extubation, averagely 30 minutes
Secondary time to response to verbal command from end of infusing anesthetics to response to verbal command,averagely 20 minutes
Secondary time to extubation from end of infusing anesthetics to extubation,averagely 28 minutes
Secondary blood pressure before and after extubation from end of infusing anesthetics to 2 minutes after extubation, averagely 30 minutes
Secondary blood glucose before and after aneurysm embolism immediately before inserting coil and after finishing inserting coil,an average of 1 hour
Secondary blood lactate before and after aneurysm embolism immediately before inserting coil and after finishing inserting coil,,an average of 1 hour
Secondary Mini-mental state examination score 24 hours after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT06033378 - Blood Pressure Treatment in ICU Patients With Subarachniodal Haemorrhage. N/A
Recruiting NCT05257824 - Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling Phase 4
Enrolling by invitation NCT06215105 - Complex Aneurysm Registry - Real-World Evidence Data Collection Intracranial Aneurysm Treatment Devices
Recruiting NCT05324605 - Personalized Treatment Planning in Intracranial Aneurysm Surgeries.
Recruiting NCT05029947 - Setting Benchmarks for Microsurgical Clipping of Unruptured Intracranial Aneurysms
Recruiting NCT05563051 - Kaneka Endovascular Embolization and Protection N/A
Recruiting NCT06123325 - Psychiatric Outcomes of Unruptured Intracranial Aneurysms (POUIA)
Enrolling by invitation NCT05441618 - Post Market Clinical Follow-Up Study on the Performance and Safety of Lyoplant®
Not yet recruiting NCT05419661 - Interest of a Simulated Procedure Performed on a Printed Model in the Endovascular Treatment of Carotid-sylvian Aneurysms N/A